• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply
Sort by Relevance
CSV RIS
Search Results [15895 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Cannabinoids for the treatment of post-traumatic stress disorder: a review of the clinical effectiveness and guidelines
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Descemet stripping automated endothelial keratoplasty: a review of the clinical and cost-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Hyperbaric oxygen therapy for autism: a review of the clinical and cost-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Casting for foot orthotics: a review of the clinical and cost-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Group therapy for mood disorders: a review of the clinical effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Group therapy for adults with axis II disorders: a review of clinical effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Group therapy for anxiety: a review of the clinical effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Group therapy in the treatment of schizophrenia: a review of the clinical effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Pathogen reduction technologies for blood products: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Lithotripsy for kidney stones or gallstones: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Aortoiliofemoral arteriogram-guided peripheral vascular stenting: a review of the clinical and cost-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Endovascular coiling versus surgical clipping: a review of the clinical and cost-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Carotid artery stenting versus carotid endarterectomy: a review of the clinical and cost-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Elective endovascular abdominal aortic aneurism repair versus open surgery: a review of the clinical and cost-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Sterilization of foot care instruments: a review of the guidelines
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Universal, community-based developmental screening tools for children 6 years and younger: a review of clinical effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Resin-bonded fixed bridges and conventional fixed bridges: a review of the advantages and disadvantages and indications
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Foot care for patients with peripheral vascular disease: a review of the guidelines
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Urine based testing for gonorrhea and chlamydia: a review of diagnostic accuracy, cost-effectiveness, and compliance
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Naltrexone for the treatment of alcohol dependence in individuals with co- dependencies: a review of the clinical effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Naltrexone in combination with acamprosate for the treatment of alcohol dependence: a review of the clinical and cost-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Organic acid testing for autism: a review of the diagnostic accuracy
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Low molecular weight heparins versus unfractionated heparin for thromboprophylaxis: a review of the cost-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Intraperitoneal chemotherapy for ovarian cancer patients: a review of the clinical and cost-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Celecoxib for post-operative pain management: a review of the clinical benefit and harm
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Oral care sponges for long-term care patients: a review of the clinical-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Botulinum toxin A for the treatment of trigeminal neuralgia and temporomandibular joint dysfunction: a review of the clinical-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Pelvic floor repair systems: a review of the clinical-effectiveness, cost- effectiveness, and guidelines
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Botulinum toxin A for headaches in adults: a review of clinical-effectiveness and safety
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Australian sheepskins for the management of pressure ulcers: a review of the clinical-effectiveness, cost-effectiveness, and guidelines
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Use of lidocaine on adults with open wounds: a review of the safety
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Methadone for the management of pain in patients with opioid addiction: a review of the evidence and guidelines for dosing recommendations
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Speech and language therapy for children of preschool age: a review of the clinical-effectiveness and quality of life
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Specifications of endosseous dental implants: a review of the advantages, disadvantages, and success rates
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Morphogenetic bone for fracture healing: a review of the clinical-effectiveness and guidelines
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Pre-operative screening for Methicillin-Resistant Staphylococcus aureus (MRSA) infection: a review of the clinical-effectiveness and guidelines
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) At home, pre-operative skin preparation: a review of the clinical-effectiveness and guidelines
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Rapid response testing for the detection of clostridium difficile: a review of the diagnostic accuracy
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Metal-ceramic and porcelain dental crowns: a review of clinical and cost- effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Endovenous laser therapy for varicose veins: a review of the clinical and cost-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Microprocessor-controlled prosthetic knees (C-Leg) for patients with above-knee amputations: a review of the clinical- and cost-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Vasopressin as first-line therapy for cardiac arrest: a review of the guidelines and clinical-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Devices for endometrial ablation therapy in the outpatient setting: clinical- and cost-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Fluoridated water for cavity prevention: a review of the clinical-effectiveness, cost-effectiveness, and guidelines
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Levothyroxine for solid organ donors: a review of the clinical-effectiveness and guidelines
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Quality assessment of the Canadian Thoracic Society guidelines for sleep disordered breathing in adults
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Botulinum toxin A for the management of pelvic pain and urinary incontinence in women: a review of the clinical-effectiveness and safety
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Non-nuclear medicine imaging technologies for cardiology: a review of alternatives to nuclear medicine imaging
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Diagnostic uses of technetium-99m: clinical conditions
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Diagnosis of snoring and obstructive sleep apnea: a review of the accuracy
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Oral appliances for treatment of snoring and obstructive sleep apnea: a review of clinical-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Use of topical anesthetics for suturing and circumcisions in pediatric patients: a review of clinical effectiveness and guidelines
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Programs to manage aggressive behaviour in long-term care patients: a review of clinical-effectiveness, cost-effectiveness, and guidelines
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Point of care testing for streptococcal sore throat: a review of diagnostic accuracy, cost-effectiveness, and guidelines
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Magnetic resonance imaging for patients with cardiomyopathy: a review of the clinical-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Magnetic resonance imaging for patients with valvular heart disease: a review of clinical-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Point-of-care HIV testing: a review of the clinical and cost-effectiveness and diagnostic accuracy
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Acupuncture for managing chronic shoulder and lower back pain: a review of optimal frequency
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Subcutaneous administration of proton pump inhibitors in palliative care patients: a review of clinical effectiveness and guidelines
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Subcutaneous lidocaine in community care: a review of the guidelines and patient safety
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Managing crohn's disease in adults: a summary of the guidelines
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Gliclazide MR versus glyburide for management of type 2 diabetes: a review of the clinical effectiveness and safety
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Sharp and round optic edges of intraocular lenses: a review of the clinical and cost-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Hypertonic saline nebules for patients with cystic fibrosis and bronchioectasis: a review of the clinical and cost-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Naltrexone for the treatment of alcohol dependence: a review of the clinical and cost-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Oral endotracheal tube placement in neonates, pediatric, and adult patients: a review of the guidelines
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Treatment of hydromyelia in adults: a review of clinical effectiveness and guidelines
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Surgical dental interventions for use in children and adults: a review of the comparative clinical and cost-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Cardiac Magnetic Resonance Imaging (MRI) for patients with coronary artery disease: a review of diagnostic accuracy
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Multi-slice computed tomography coronary angiography for coronary artery disease: a review of the clinical effectiveness and guidelines
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Follow-up to 'The role of pharmacologic management in neovascular age- related macular degeneration: clinical and cost-effectiveness'
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Indirect calorimetry to measure energy requirements: a review of the guidelines and clinical effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) C-reactive protein levels for cardiovascular disease screening: a review of accuracy, use, and guidelines
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Chiropractic interventions for acute or chronic lower back pain in adults: a review of the clinical and cost-effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Alvimopan for surgical patients: a review of the clinical and cost-effectiveness
2009 NIHR Health Technology Assessment programme Fludarabine phosphate for the first-line treatment of chronic lymphocytic leukaemia
2009 NIHR Health Technology Assessment programme Bortezomib for the treatment of multiple myeloma patients
2009 NIHR Health Technology Assessment programme Rituximab for the first-line treatment of stage III/IV follicular non-Hodgkin's lymphoma
2009 NIHR Health Technology Assessment programme The use of paclitaxel in the management of early stage breast cancer
2009 Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Autism treatment with orthomolecular therapy]
2009 Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Systematic review of efficacy and safety in Cyberknife radiosurgery: indications and results in the treatment for intra and extracranial lesions]
2009 Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Laparoscopic hysterectomy and lymphadenectomy efficacy and safety in endometrial cancer]
2009 Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Photodynamic therapy effectiveness and safety in nonmelanoma skin cancer]
2009 Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Photodynamic therapy effectiveness, safety and cost-effectiveness in oesophagus cancer and Barrett oesophagus treatment]
2009 Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Appropriateness use standards for health technologies : appropriate admission explicit criteria for heart failure (HF)]
2009 Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Effectiveness, safety and indications of da Vinci Surgical System]
2009 Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Systematic review and cost-effectiveness analysis of radiofrequency ablation in liver tumors and metastases]
2009 Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Assessment of the re-designed diagnosis process for colorectal cancer]
2009 Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Efficacy and safety of 64-multislice CT: a systematic review]
2009 Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Standards for the appropriate use of health technologies. Pharmacological treatment of bipolar disorder]
2009 VA Technology Assessment Program (VATAP) Systematic reviews for localized prostate cancer
2009 The Regional Health Technology Assessment Centre (HTA-centrum) Abdominal plastic surgery after massive weight reduction
2009 The Regional Health Technology Assessment Centre (HTA-centrum) [Intraoperative magnetic resonance imaging in neurosurgery]
2009 The Regional Health Technology Assessment Centre (HTA-centrum) [Treatment of pseudomyxoma peritonei]
2009 The Regional Health Technology Assessment Centre (HTA-centrum) [Sacral nerve stimulation (SNS) for fecal incontinence]
2009 The Regional Health Technology Assessment Centre (HTA-centrum) [Treatment of early rheumatoid arthritis with a combination of TNF-alpha inhibitors and methotrexate, versus methotrexate alone]
2009 The Regional Health Technology Assessment Centre (HTA-centrum) [Effect of atrial natriuretic peptide, ANP, on the need for dialysis, when used as treatment or prevention of acute renal failure in intensive care]
2009 The Regional Health Technology Assessment Centre (HTA-centrum) [Percutaneous pulmonary valve insertion for patients needing right ventricular outflow reintervention]
2009 The Regional Health Technology Assessment Centre (HTA-centrum) [Diagnostic colon evaluation in patients with suspected colorectal neoplasia or at high risk of colorectal neoplasia - a comparison of double contrast barium enema (DCBE), CT colonography and colonoscopy]
2009 The Regional Health Technology Assessment Centre (HTA-centrum) [Probiotics in the prevention of clostridium difficile-associated colitis and antibiotic associated diarrhea in adult in-patients]